Artisan Partners, an investment management company, released its “Artisan Small Cap Fund” fourth quarter 2024 investor letter ...
13h
Investor's Business Daily on MSNHalozyme Stock Offers Early Buy Point As Company Hits $1 Billion In RevenueHalozyme stock is in a consolidation pattern but its chart shows an alternate entry. The biotech name hit two milestones in ...
16h
Zacks.com on MSNIs Brookdale Senior Living (BKD) Stock Outpacing Its Medical Peers This Year?Here is how Brookdale Senior Living (BKD) and Halozyme Therapeutics (HALO) have performed compared to their sector so far this year.
HC Wainwright reiterated their buy rating on shares of Halozyme Therapeutics (NASDAQ:HALO – Free Report) in a report published on Thursday,Benzinga reports. Several other equities analysts have also ...
GSK’s ViiV Healthcare has shared clinical data on three potential long-acting HIV treatments, providing a look at how its ...
In a report released today, Mitchell Kapoor from H.C. Wainwright reiterated a Buy rating on Alumis Inc. (ALMS – Research Report), with a price ...
In a report released today, Brendan Smith from TD Cowen maintained a Buy rating on 908 Devices (MASS – Research Report). The company’s shares ...
US biotech Halozyme Therapeutics has withdrawn its offer to acquire Evotec, saying that the German company had been "unwilling to engage with us to explore a potential combination." Halozyme made ...
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results